| CORP. SALE | Piperidine-1-{CH2CH2C[CO-N(Me)2](Et)2}-4-OH-4-(C6H4-Cl) |
| CLASSIFICATION | CommPat |
| MECHANISM OF ACTION | Opioid. It reduces intestinal transit, intensifies intestinal absorption of water & ions & fortifies rectal sfincter tone, improving with this the diarrhea & fecal incontinence |
| METHOD | 2-4 mg up to 4 times a day |
| STATUS | Patent expired |
| THERAPEUTIC CLASS | Antidiarrheal |
| UPDATE | 08.00 |
| LITERATURE REF. | Francis CY, Whorwell PJ. The irritable bowel syndrome. Postgraduate Med J 1997;73:1-7 |
| PATENT ASSIGNEE | This data is not available for free |
| PATENT PHOTOCOPY | Available on request |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |